CD163 and colorectal carcinoma: Interestingly, in this study, the ratio of CD163+/CD68+ at the invasive front seemed to be correlated with the expression of EMT markers as well as with clinicopathological parameters, proposing the use of this ratio as a prognostic marker of CRC treatment because of its association with poor prognosis.